MOOD — Doseology Sciences Balance Sheet
0.000.00%
Last trade - 00:00- CA$5.45m
- CA$4.12m
- CA$0.04m
- 56
- 13
- 55
- 35
Annual balance sheet for Doseology Sciences, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 3.73 | 1.87 | 1.3 | 1.06 | 1.43 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.044 | 0.085 | 0.017 | 0.002 | 0.041 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 5 | 2.97 | 1.34 | 1.1 | 1.49 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.907 | 0.883 | 0.056 | 0 | — |
| Net Intangible Assets | |||||
| Total Assets | 5.99 | 3.87 | 1.4 | 1.1 | 1.49 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.41 | 0.219 | 0.092 | 0.082 | 0.094 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 3.41 | 0.872 | 0.099 | 0.082 | 0.094 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 2.58 | 3 | 1.3 | 1.02 | 1.4 |
| Total Liabilities & Shareholders' Equity | 5.99 | 3.87 | 1.4 | 1.1 | 1.49 |
| Total Common Shares Outstanding |